Watermark
  Back to Search Results

BGB-dinutuximab beta-101

Completed

Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma

BeOne Study ID info

BGB-dinutuximab beta-101

ClinicalTrials.gov ID info

NCT05373901

China Drug Trials ID info

CTR20221154

Study Overview

Sex: All

Age: 12 Months / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 12 Months / N/A

Study Documents

Study Protocol Statistical Analysis Plan